Search alternatives:
latency decreased » rate decreased (Expand Search)
largest decrease » larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
a latency » _ latency (Expand Search), c latency (Expand Search), se latency (Expand Search)
b marked » _ marked (Expand Search), a marked (Expand Search), n marked (Expand Search)
latency decreased » rate decreased (Expand Search)
largest decrease » larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
a latency » _ latency (Expand Search), c latency (Expand Search), se latency (Expand Search)
b marked » _ marked (Expand Search), a marked (Expand Search), n marked (Expand Search)
-
1
-
2
-
3
-
4
-
5
Effects of increasing amounts of gravel on escape latency and aversiveness of gravel.
Published 2025“…<p>(A) Escape latency during trial 1 was higher when greater amounts of gravel were in the connecting chamber. …”
-
6
-
7
-
8
Effects of increasing gravel on initial escape latency in non-injured <i>vs.</i>
Published 2025“…</b> However latency was significantly decrease for the 40 g condition in the injured day 0 animals. **** indicates significant differences across increasing amounts of gravel (p < 0.0001). * indicates a post-hoc test confirming a significant difference between injured and non-injured animals 40 g (p < 0.05).…”
-
9
Raw data of the charts in Fig 5.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
10
Antibodies used in western blot analysis.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
11
Raw data of the charts in Fig 3.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
12
Raw data of the charts in Fig 1.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
13
Raw data of the charts in Fig 6.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
14
Raw data of the charts in Fig 2.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
15
-
16
<b>Effect of Marked Weight Loss on Adipose Tissue Biology in People with Obesity and Type 2 Diabetes</b>
Published 2025“…</p><p dir="ltr"><b>Results: </b>Weight loss: <a href="" target="_blank">i) </a><a href="" target="_blank">decreased adipose tissue </a>expression of genes related to extracellular matrix remodeling; ii) decreased adipose tissue expression of SERPINE 1 which encodes plasminogen activator inhibitor-1 (PAI-1); iii) did not decrease adipose tissue immune cell content or expression of genes involved in inflammation; iv) decreased adipose tissue ceramide content; v) decreased plasma <a href="" target="_blank">PAI-1 </a>and leptin concentrations and increased plasma high-molecular weight (HMW) adiponectin; and vi) decreased plasma small extracellular vesicle (sEV) concentration and the sEV content of microRNAs proposed to inhibit insulin action, and completely reversed the inhibitory effect of plasma sEVs on insulin signaling in myotubes.…”
-
17
-
18
EA inhibited the DNMT3a overecpression and restore MOR expression in the CCI rats DRG.
Published 2025Subjects: -
19
-
20